PARKINSON DISEASE
Prospects for cannabinoid therapies in basal ganglia disorders (PubMed)
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease:
Importance of antioxidant and cannabinoid receptor-independent properties (PubMed)
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro:
relevance to Parkinson’s disease (PubMed)
Cannabidiol can improve complex sleep-related behaviours associated with rapideye movement sleep behaviour disorder in Parkinson’s disease patients: a caseseries (PubMed)
Cannabidiol for the treatment of psychosis in Parkinson’s disease (PubMed)
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease (PubMed)
Therapeutic potential of cannabinoids in CNS disease (PubMed)
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial. (PubMed 2014)
Dorsolateral Prefrontal Cortex N-Acetylaspartate/Total Creatine (NAA/tCr) Loss in Male Recreational Cannabis Users (Research Gate/PubMed 2007)
Cannabidiol for the treatment of psychosis in Parkinson’s disease. (PubMed 2008)